Elisabeth I Heath

51PUBLICATIONS
438CO-AUTHORS
ChemotherapyPredictive and prognostic markersInnate immunityMolecular targetsPacific Peoples social, cultural, emotional and spiritual wellbeing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Aug 01, 2026
Paclitaxel and carboplatin after disease progression on immune checkpoint inhibitor for patients with metastatic urothelial carcinoma.

|Apr 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer.

|Feb 27, 2026
Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid Tumors.

John R Lozada, Atef Ali, Christine Luo

|Sep 16, 2025
Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP).

Irene Tsung, David C Smith, Elisabeth I Heath

|Aug 12, 2025
Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes.

Nicholas A Zorko, Allison Makovec, Andrew Elliott

|Jul 25, 2025
Off-pore Nucleoporin sPOM121 Transcriptionally Propels β-Catenin-driven Tumor Progression and Immune Escape in Prostate Cancer.

Perumalraja Kirthika, Vijayakumar Jawalagatti, Peiyao Li

Pageof 9

Frequent Collaborators

15 joint publications

Emmanuel S Antonarakis

15 joint publications

Rana R McKay

8 joint publications

Andrew Elliott

6 joint publications

Andrew J Armstrong